首页> 外国专利> Predicting suicide propensity using combined genomic and clinical risk assessment

Predicting suicide propensity using combined genomic and clinical risk assessment

机译:结合基因组和临床风险评估预测自杀倾向

摘要

Disclosed are biomarkers and methods for screening biomarker expression levels for predicting suicide propensity (herein indicative of suicidal ideation and behavior, future hospitalization and suicide completion). In addition, quantitative questionnaires and mobile applications for assessing emotional status and assessing sociodemographic and psychological suicide risk factors and their use to calculate scores that can predict suicide propensity Is disclosed. Finally, an algorithm for combining biomarkers and computer apps to identify subjects at risk of suicide is disclosed, and a method for reducing and preventing suicide propensity based on biomarkers and computer apps is disclosed . [Selection] Figure 3A
机译:公开了生物标志物和用于筛选生物标志物表达水平以预测自杀倾向的方法(在此表明自杀意念和行为,未来的住院治疗和自杀完成情况)。此外,公开了用于评估情绪状态以及评估社会人口统计学和心理自杀风险因素的定量问卷和移动应用程序,以及它们用于计算可预测自杀倾向的分数的用途。最后,公开了一种用于组合生物标记物和计算机应用程序以识别有自杀风险的对象的算法,并且公开了一种基于生物标记物和计算机应用程序的减少和预防自杀倾向的方法。 [选择]图3A

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号